[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-356618-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-356618-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","re-expression-of-embryonic-stem-cell-markers-in-malignant-tissue-an-observational-study-in-pancreatic-cancer","Re-expression of embryonic stem cell markers in malignant tissue - an observational study in pancreatic cancer","","Pancreatic cancer is a lethal malignancy driven by late diagnosis and limited treatment options. Cancer stem cells (CSCs) support tumor heterogeneity, therapy resistance, and recurrence through developmental programs such as Hedgehog, Wnt, Notch, JAK-STAT, and Hippo. This observational study compares CSC-associated marker expression (CD44, CD117, OCT3/4, c-Myc) across PDAC, fetal pancreas, and adult pancreas. Immunohistochemistry assesses these markers and proliferation potential via CK7 and Ki-67 patterns, showing developmental reactivation implications for early detection and targeted therapy.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/re-expression-of-embryonic-stem-cell-markers-in-malignant-tissue-an-observational-study-in-pancreatic-cancer/356618/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/re-expression-of-embryonic-stem-cell-markers-in-malignant-tissue-an-observational-study-in-pancreatic-cancer/356618.png","ImageObject",300,407,{"name":42,"@type":43},"Sophia Brooks","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-01","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main goal of this observational study in pancreatic cancer?","Question",{"text":63,"@type":64},"To compare the expression of embryonic stem cell/CSC-associated markers in PDAC versus fetal and adult pancreatic tissues and clarify CSC dynamics.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which markers were evaluated to characterize cancer stem cell–associated expression?",{"text":68,"@type":64},"CD44, CD117, OCT3/4, and c-Myc were assessed by immunohistochemistry across PDAC and control pancreatic samples.",{"name":70,"@type":61,"acceptedAnswer":71},"How did marker expression differ between PDAC, fetal pancreas, and adult pancreas?",{"text":72,"@type":64},"CD44 was strong in PDAC, moderate in fetal ductal/epithelial regions, and minimal in adult tissue; CD117 appeared mainly in PDAC stromal cells and was low in adults, while c-Myc and Ki-67 were higher in PDAC than controls.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},356618,1790478055,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":123,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},962084925636,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Original Article  \n[https://doi.org/10.5115/acb.25.310](https://doi.org/10.5115/acb.25.310)[ ](https://doi.org/10.5115/acb.25.310)eISSN 2093-3673  \nRe-expression of embryonic stem cell markers in malignant tissue: an observational study in pancreatic cancer  \nSashikanta Swain1, Sipra Rout1, Sarojini Raman2, Praveen Kumar Ravi1, SruthyBabu3, Pravash Ranjan Mishra1 1Department of Anatomy, All India Institute of Medical Sciences, Bhubaneswar, 2Department of Pathology, All India Institute of Medical Sciences, Bhubaneswar, 3Department of Anatomy, All India Institute of Medical Sciences, Jodhpur, India  \nAbstract: Pancreatic cancer is one of the most lethal malignancies, primarily due to late-stage diagnosis and limited therapeutic options. Cancer stem cells (CSCs) contribute to tumor heterogeneity, therapy resistance, and recurrence through activation of developmental pathways such as Hedgehog, Wnt, Notch, JAK-STAT, and Hippo. Identifying CSCs is therefore essential for understanding pancreatic ductal adenocarcinoma (PDAC) pathogenesis and advancing targeted therapies. This study compares the expression of key CSC-associated markers (CD44, CD117, OCT3/4, and c-Myc) in PDAC, fetal, and adult pancreas to elucidate CSC dynamics. Immunohistochemistry for CSC markers (CD44, CD117, OCT3/4, and c-Myc) was performed on PDAC tissues and control pancreatic samples (fetal pancreas 28–36 weeks and adult pancreas) to evaluate marker expression. Proliferative potential was assessed using CK7 and Ki-67 expression patterns. CD44 showed strong membranous and cytoplasmic expression in PDAC, moderate in fetal pancreas (epithelial/ductal regions), and minimal expression in adult tissue. CD117 was mainly restricted to stromal cells in PDAC, also present in fetal tissue but low in adults. c-Myc and Ki-67 were moderately expressed in PDAC, significantly higher than the control samples. CK7 demonstrated strong cytoplasmic staining in PDAC, moderate expression in adults, and weak expression in fetal samples. CD44 and c-Mycre-expression in PDAC supports their role as CSC-associated markers and potential drivers of tumor progression. CD117’sstromal localization suggests tumor–stroma interactions. These findings highlight developmental reactivation of CSC markers in PDAC, with implications for early detection and targeted therapy.  \nKey words: Carcinoma, pancreatic ductal, Stem cells, Immunohistochemistry  \nReceived September 29, 2025; Revised October 18, 2025; Accepted November 17, 2025  \nIntroduction  \nPancreatic cancer stands as one of the most lethal malignancies worldwide, largely due to its aggressive biology, late clinical presentation, and dismal survival rates despite  \nCorresponding author:  \nPravash Ranjan Mishra   \nDepartment of Anatomy, All India Institute of Medical Sciences, Bhubaneswar 751019, India  \n[E-mail: mishra.pravash@yahoo.com](E-mail: mishra.pravash@yahoo.com)  \nsignificant research efforts. Current statistics reveal that the global 5-year survival rate for pancreatic cancer is roughly 11%. Pancreatic cancer is presently the seventh leading cause of cancer-related mortality globally and is projected to become the second leading cause of death worldwide by 2030 [1]. Current evidence suggests that pancreatic ductal adenocarcinoma (PDAC) may originate from a small subset of aberrant stem cells endowed with uncontrolled proliferative capacity [2].  \nStem cells possess the remarkable ability to modulate the inflammatory microenvironment through the release of paracrine factors such as cytokines and growth factors, and  \n© 2026. Anatomy & Cell Biology  \nThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ([http://creativecommons.org/licenses/by-nc/4.0/](http://creativecommons.org/licenses/by-nc/4.0/)) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.  \n116 Anat Cell Biol 2026;59:115-124 S","cbCaitUbWQzsnlDl","https://ap.wps.com/l/cbCaitUbWQzsnlDl","pdf",8699966,"English","# Abstract\n# Introduction","[{\"question\":\"What is the main goal of this observational study in pancreatic cancer?\",\"answer\":\"To compare the expression of embryonic stem cell/CSC-associated markers in PDAC versus fetal and adult pancreatic tissues and clarify CSC dynamics.\"},{\"question\":\"Which markers were evaluated to characterize cancer stem cell–associated expression?\",\"answer\":\"CD44, CD117, OCT3/4, and c-Myc were assessed by immunohistochemistry across PDAC and control pancreatic samples.\"},{\"question\":\"How did marker expression differ between PDAC, fetal pancreas, and adult pancreas?\",\"answer\":\"CD44 was strong in PDAC, moderate in fetal ductal/epithelial regions, and minimal in adult tissue; CD117 appeared mainly in PDAC stromal cells and was low in adults, while c-Myc and Ki-67 were higher in PDAC than controls.\"}]","Re-expression of embryonic stem cell markers in malignant tissue - an observational study in pancreatic cancer | PDF",1790126328,25,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1732fd69333133b5186d4dd382549025.webp",983,1310,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0050a33d147075680c0f48225cd0e711.webp",982,1309,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/27bc9167fa9f4fb8260a059f6180a966.webp",981,1308,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5c37db417ce81479173d091f17ef59dd.webp",980,1306]